Accuracy of Blood Loss Estimation After Vaginal Delivery: Complete Statistical Analysis

1. Trial at a Glance

This page covers the registry results for Accuracy of Blood Loss Estimation After Vaginal Delivery (NCT00462839), a randomized na study. The primary outcome is Difference in Actual Blood Volume and Estimated Blood Volume in Milliliters..

2. Clinical Question

The clinical question concerns measurement accuracy, not a clinical treatment effect. The registry describes blood mixed with urine and surgical sponges in a collection bag, and identifies visual estimation as the practice being studied. It also notes uncertainty about whether provider type or experience affects accuracy, and whether graduated drape markings could improve estimation. The study therefore compares estimates made after viewing calibrated and non-calibrated drapes in a simulated delivery context.

The comparison is within the same individuals, while the order of viewing was randomized. This setup can examine how estimates differ between drape types while accounting for the fact that the same person contributes estimates under both conditions. However, the registry does not report the numerical results, the exact signed-difference convention, or results broken down by provider type or experience. It therefore does not establish from the registry record how large or precise any difference was.

3. Trial Design

This was a randomized, single-masked, crossover study. The registry lists enrollment as 106 and the status as completed. The start is recorded as 2006-07 and primary completion as 2008-04. The study is listed as not applicable for phase and identifies Northwestern University as the sponsor.

Care providers estimated blood volume using two drape conditions: calibrated and non-calibrated. In one sequence, caregivers viewed calibrated drapes first and then non-calibrated drapes. In the other sequence, they viewed non-calibrated drapes first and then calibrated drapes. The registry describes the same individuals as crossing over to the other drape condition. The sequence was randomized, so the order of exposure was assigned rather than chosen by the participant or study team, according to the registry description.

The exercise was simulated: caregivers were shown a drape and asked to estimate the volume in its collection bag. Calibrated drapes had markings beginning at 500ml, in 500ml increments, up to 2500ml. The record does not describe a clinical-care intervention or report patient outcomes. It identifies postpartum hemorrhage as a condition of interest, but the primary outcome is estimation accuracy, not the occurrence or treatment of hemorrhage.

The registry identifies a per-protocol population (spelled “per protocal” in the record) for the primary outcome. It lists 53 participants at risk in each sequence in the serious-adverse-event entries. Those safety entries do not clarify how many participants contributed usable estimates to each outcome, whether any observations were excluded, or how missing observations were handled. The identity of the masked party and the procedures used to maintain masking are not reported in the registry record. Further details of the crossover analysis, such as adjustment for order or period, are also not reported.

4. Participant Flow and Accounting

The registry reports how participants moved through each stage of the study. All counts below are exactly as posted; missing counts are not inferred from other stages.

Viewed First

Viewed Second

Analysis population for the primary outcome, as defined in the registry: per protocal

5. Baseline Characteristics

The table reproduces the baseline characteristics posted in the registry, which describe the participants analysed at baseline and help show whether the randomized groups were comparable.

6. Primary Endpoint

The registry lists the primary outcome as Difference in Actual Blood Volume and Estimated Blood Volume in Milliliters., measured over 1 hour.

The primary endpoint is the difference between actual blood volume and estimated blood volume, expressed in milliliters. The registry describes asking participants to estimate the volume in the collection bag and calculating a difference between that estimate and the actual volume. It specifies a mean as the summary measure and a 95% confidence interval as the measure of dispersion, with a timeframe of 1 hour.

This endpoint is intended to quantify estimation error. Comparing estimates with an actual volume can show whether estimates tend to be displaced from the measured amount, and by how much, in the study conditions. In general, a mean summarizes the average value of a set of measurements; a confidence interval conveys uncertainty around that estimated mean. A narrower interval indicates greater precision than a wider interval, but the interval alone does not determine whether a difference is practically important.

The registry does not state whether the difference was calculated as estimate minus actual volume or actual minus estimate. That convention matters for interpreting the direction of a signed result. Nor does the registry record provide the numerical mean differences or their confidence limits. It describes calibrated markings starting at 500ml and proceeding in 500ml increments to 2500ml, but does not report the specific actual-volume conditions used for each estimate. Without the numerical results and condition-level details, the magnitude, direction, and precision of the endpoint cannot be assessed from the registry record.

7. Why No Re-analysis Is Shown

8. Statistical Interpretation

9. Statistical Methods Explained

The registry identifies a randomized crossover design and a continuous primary outcome summarized as a mean with a 95% confidence interval. These details describe the intended comparison and its summary, but do not reveal the actual statistical model or the numerical findings. The methods below explain the general statistical ideas relevant to this design; they should not be taken as a description of unreported analysis procedures.

What does randomization of viewing order contribute?

In a crossover study, participants encounter more than one condition, and the order of those conditions can matter. Randomizing the order helps prevent systematic differences in assignment sequence from being chosen by participants or investigators. In this study, the registry describes one sequence starting with calibrated drapes and another starting with non-calibrated drapes. Randomized order can help separate condition differences from order-related influences, but it does not by itself show that order effects were absent or appropriately modeled.

The same individuals contributed estimates under both drape conditions, according to the registry. That creates paired observations: each person’s estimates can be compared across conditions. In general, paired analysis uses the relationship between measurements from the same individual, rather than treating all measurements as unrelated. This can improve precision when an individual’s two measurements tend to be similar. The registry does not report whether the primary analysis used a paired method, how it accounted for sequence, or whether it assessed period or carryover effects.

What does a mean difference describe?

The primary endpoint concerns the difference between actual blood volume and estimated blood volume. A mean difference summarizes the average signed error across observations. If the estimate is below actual volume under a chosen sign convention, the signed difference will point one way; if it is above, the sign will point the other way. The record does not specify which subtraction order was used, so the direction of a hypothetical signed result cannot be interpreted from the description alone. In general, signed errors can also conceal variation: estimates that are too high and too low can offset in an average. The registry does not report a separate absolute-error measure.

The actual and estimated volumes are continuous quantities, and the endpoint is reported in milliliters. The registry specifies a mean and 95% confidence interval. A confidence interval expresses uncertainty in an estimated parameter under the assumptions of the analysis. It is not a range containing every individual measurement, nor does it by itself describe measurement variability among participants. The interval’s width is informative about precision, while its location conveys the values compatible with the estimate under the method used. In this record, neither the means nor their confidence limits are reported, so precision cannot be judged.

Why does the distribution matter?

In general, statistical methods for means often rely on assumptions about the distribution of observations or model residuals. A small number of unusually large errors can affect a mean, and unequal variability across conditions can influence the reliability of standard errors and confidence intervals. Over-dispersion, in general, means variability is greater than a model assumes; if not accounted for, uncertainty may be understated. These are general considerations, not reported features of this study. The registry record does not describe the data distribution, diagnostic checks, transformation, robust methods, or model specification.

How should the reported confidence interval be read?

For a mean difference, the interval gives a range of values that are reasonably compatible with the data and the statistical procedure, under the method’s assumptions. It communicates precision rather than certainty. A confidence interval that is broad indicates less precise estimation than a narrow interval. Whether an interval includes a particular value can be relevant to a statistical contrast, but it is not a substitute for judging the size and practical meaning of the difference. Since the registry does not list the numerical interval or the comparison-specific estimates, these considerations cannot be applied to the study’s observed results.

The record says the primary outcome has several categories or time points and is not reduced to one comparison. When multiple outcomes, conditions, or time points are examined, the chance of at least one apparently unusual result can increase if each is tested separately. General approaches to multiplicity include prespecifying a primary comparison, adjusting inference, or emphasizing estimation and interpreting related results together. The registry does not report which approach, if any, was used. It also does not give category-specific estimates or a statistical analysis plan.

What can the design description not establish?

Study design details do not replace outcome data. Randomization describes allocation of viewing order; crossover describes exposure to both drape types; and a continuous endpoint describes the measurement. None of these tells the reader the observed difference. The registry does not report the estimated means, confidence limits, analysis model, missing-data method, or an inferential test for the primary outcome. It also does not state whether the analysis adjusted for provider characteristics. These absences prevent a reconstruction of the study’s statistical conclusions from the registry record.

The sample-size illustrations are planning calculations based on an observed effect, with a two-sided significance level of 0.05, equal allocation, and a normal approximation. Such calculations are hypothetical planning aids: they describe the number of participants per arm associated with a chosen effect and power assumption, not the power actually achieved by a completed study. The registry record does not report the observed effect or numerical planning outputs, so no sample-size illustration can be interpreted quantitatively. These planning calculations also do not establish what rationale or analysis the investigators used when designing the trial.

10. Multiplicity, Missing Data and Analysis Populations

The primary outcome is described as having several categories or time points, and the registry record does not reduce it to one comparison. It does not report category-specific numerical results, a prespecified hierarchy among comparisons, or an adjustment for multiple testing. When several comparisons are examined, chance variation can produce apparently notable findings even when no underlying difference exists. In general, a statistical plan can address this through prespecification, multiplicity adjustment, or an emphasis on estimation and uncertainty across the full set of comparisons. Which, if any, approach was used is not reported in the registry record.

The registry labels the primary-outcome population as “per protocal.” It does not explain the eligibility rules used for that analysis or report how many participants contributed usable observations to each condition. Missing observations, exclusions, withdrawals, and the method used to handle missing data are not reported in the registry record. These details matter because a per-protocol analysis may differ from an analysis that includes everyone as assigned, particularly if exclusions are related to the estimates or study conditions.

The randomized crossover structure also raises analysis questions about paired measurements, sequence, period, and possible carryover. The record does not say how these were handled, or whether the analysis included adjustments for provider type, training, or clinical experience. The statistical analysis plan, interim analyses, and sample-size justification are not reported in the registry record. No specific inference about multiplicity control, missing-data assumptions, or the analysis population beyond the registry’s label can therefore be made.

11. Safety Results

The registry reports serious adverse events as affected participants divided by participants at risk.

Other (non-serious) adverse events

Participants with at least one non-serious event at or above the registry's 0% reporting threshold.

The serious-adverse-event entries list 53 at risk in each viewing-order sequence. For both sequences, the registry records 0 serious events and 0 other events. The deaths field is null for each sequence; a null entry means the death count is not reported in the registry record, rather than establishing a reported zero.

These entries describe the registry’s safety fields, not the primary estimation-accuracy outcome. The study involved simulated viewing and estimation, and the record does not describe a clinical treatment comparison. The adverse-event entries should not be interpreted as evidence that the drapes have a particular safety profile in clinical care. The registry does not provide definitions of serious or other events, the method of collecting events, or additional detail on timing and follow-up. It also does not explain whether the at-risk entries correspond to all enrolled participants or to another safety population.

Because the design is crossover, the two sequence groups represent order assignments, while the same individuals are described as viewing both types of drape. The entries should therefore be read as registry-reported sequence-specific safety counts, not as proof that each drape condition was independently evaluated in separate groups. The record provides no narrative event descriptions. The zero entries indicate that no events were recorded in those fields; the null death entries remain unreported.

12. What the Result Does, and Does Not, Mean

This study addresses a practical measurement question: whether caregivers’ estimates of blood volume differ when they view a calibrated rather than a non-calibrated vaginal delivery drape. Its crossover design has the same individuals estimate volume in both conditions, and the primary endpoint is the mean difference between actual and estimated volume. The registry record describes the design and endpoint but does not report numerical outcome estimates or confidence intervals.

As a result, the record does not show how close the estimates were to actual volumes, whether one drape condition yielded smaller errors, or how precise any comparison was. It also does not show whether estimates varied by provider type, training level, or years of clinical experience. Although these factors are listed among secondary outcomes, their results are not reported in the registry record. The absence of posted estimates cannot be interpreted as evidence that the drape conditions performed alike or that no difference was observed.

The simulated setting also limits what the design description alone can establish about routine clinical use. The registry describes caregivers estimating volume in a collection bag; it does not report clinical outcomes or patient-level consequences. The record does not specify whether the observed estimates reflect the full range of circumstances in actual deliveries. Nor does it report the specific actual-volume conditions used for each observation, the signed-difference convention, or the analysis of the multiple categories or time points.

The result that can be stated from the registry is therefore about the research question and measurement approach, not the comparative performance. A numerical result with its uncertainty, along with details of the analysis population and handling of the crossover design, would be needed to assess the size, direction, and precision of any observed difference. Nothing in the registry description alone warrants a conclusion about clinical benefit, harm, or the performance of a drape in practice.

13. Why This Trial Matters Statistically

Blood-volume estimation is a measurement problem: the quantity of interest is not the estimate itself, but how the estimate relates to actual volume. A study that defines an endpoint as the difference between actual and estimated volume makes that distinction explicit. Reporting a mean and confidence interval can, in principle, communicate both the average discrepancy and its precision. In this registry record, those numerical results are absent, which makes the distinction between a well-defined research question and an interpretable result especially important.

The crossover design is statistically relevant because the same caregivers viewed both drape types. Comparisons can then account for within-person pairing rather than relying only on differences between unrelated groups. Randomizing which drape type was viewed first also addresses order assignment in the design. But these advantages depend on appropriate analysis and adequate reporting; the registry does not state how pairing, order, or possible period effects were modeled.

The study also names provider type and experience as possible influences on estimation. These characteristics could be important sources of variation in a measurement task, but the registry record does not report subgroup findings. Without results, readers cannot distinguish a general pattern from variation among provider groups, or assess the uncertainty in any such pattern.

Finally, the record illustrates why a study’s design, endpoint, and outcome results must be read separately. A randomized crossover study can be suitable for comparing conditions, but design labels do not reveal the observed contrast. The endpoint definition explains what the investigators intended to measure, while the missing estimates prevent an assessment of magnitude and precision. Statistical interpretation depends on all three: the question, the measurement, and the reported evidence.

14. Limitations

• The posted summary statistics are the only data these results rest on; patient-level data, full protocols and statistical analysis plans are not available.
• Recalculated results are simple, unadjusted calculations from posted summaries. They do not replace the sponsor's prespecified analysis.

The main limitation of interpretation is that the registry record does not report numerical primary-outcome results. It identifies a mean difference and a 95% confidence interval but gives no estimates or confidence limits. The primary outcome is also described as involving several categories or time points without one comparison, and the record does not list the category-specific results. Consequently, the direction, magnitude, precision, and consistency of findings cannot be assessed.

The outcome description leaves important details unresolved. It does not specify the subtraction order for the difference between actual and estimated volume, so the direction of a signed value cannot be inferred. Although it states that calibrated markings began at 500ml and advanced in 500ml increments to 2500ml, the record does not say which actual-volume conditions contributed to each comparison. The registry also does not provide separate absolute errors or other summaries of variability.

For the crossover, it does not report how paired measurements or randomized sequence were included in analysis, whether order or period effects were considered, or how possible carryover was assessed. The identity of the masked party is not stated. The record does not report the participant characteristics or results by provider type, training level, or years of experience, despite listing these as secondary outcomes.

Missing-data rules, exclusions, withdrawals, analysis details, multiplicity handling, and the sample-size justification are not reported in the registry record. The label “per protocal” does not explain the analysis population’s operational definition. The simulated estimation task also does not, by itself, establish how results would relate to estimates during actual delivery care. These limitations concern what can be interpreted from the registry record; they do not establish that the underlying study lacked additional analyses.

15. Related Tutorials

16. Related Statistical Calculators

17. Sources

• ClinicalTrials.gov: Accuracy of Blood Loss Estimation After Vaginal Delivery — NCT00462839.
• Registry record last updated 2014-04-14; status last verified 2014-03.
• Results first posted 2011-12-09.
• Data retrieved from ClinicalTrials.gov on 2026-11-09.
• Group sizes, means, event counts and sponsor-reported p-values are reproduced as posted. Effect estimates, confidence intervals and p-values not attributed to the sponsor are independently calculated from the posted summary statistics.

18. Record Summary

The registry lists NCT00462839, “Accuracy of Blood Loss Estimation After Vaginal Delivery,” as a completed randomized, single-masked crossover study sponsored by Northwestern University. Enrollment is recorded as 106. The study start is 2006-07 and primary completion is 2008-04; the phase is listed as not applicable.

Caregivers estimated blood volume after viewing calibrated and non-calibrated vaginal delivery drapes, with viewing order randomized and participants crossing over between conditions. The primary outcome is the difference between actual and estimated blood volume, summarized as a mean with a 95% confidence interval and a timeframe of 1 hour. The registry record does not report numerical primary-outcome results, category-specific estimates, or confidence limits. It lists 0 serious and 0 other adverse events in each viewing-order sequence; deaths are not reported.